Lv1
16 积分 2024-03-23 加入
PSMA-Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P-Glycoprotein and Inactivate Myeloid-Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate Cancer
5个月前
已完结
PSMA-Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P-Glycoprotein and Inactivate Myeloid-Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate Cancer
5个月前
已完结
A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic Immunotherapy
6个月前
已完结
Self-assembly GSH response based peptide-drug nanocombination synergistically promotes DNA damage for prostate cancer immunotherapy
6个月前
已完结
Composition‐Reinforced Polydopamine Nanoenzyme for Improved Impairment of Prostatitis‐Damaged Sexual Behavior and Enhanced Anti‐Prostate Cancer
7个月前
已完结
Glucose Metabolism‐Targeted Poly(amino acid) Nanoformulation of Oxaliplatin(IV)‐Aspirin Prodrug for Enhanced Chemo‐Immunotherapy
7个月前
已完结
PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer
8个月前
已完结
Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives
9个月前
已完结
Composition‐Reinforced Polydopamine Nanoenzyme for Improved Impairment of Prostatitis‐Damaged Sexual Behavior and Enhanced Anti‐Prostate Cancer
9个月前
已完结
Boosting ubiquitin-proteasome system-mediated androgen receptor degradation and cGAS-STING pathway activation for synergistic prostate cancer therapy by engineered zinc-manganese oxide nanoparticles
9个月前
已完结
皖公网安备34019202002308
